Brief: Morgan Stanley Reports 10.3% Passive Stake In Arbutus Biopharma Corp As Of May 31- SEC Filing
Arbutus Biopharma Corp ABUS.O :
* MORGAN STANLEY REPORTS 10.3% PASSIVE STAKE IN ARBUTUS
BIOPHARMA
CORP AS OF MAY 31- SEC FILING
Source text for Eikon: ID:n0000895421-24-000390
Further company coverage: ABUS.O
Recent news on Arbutus Biopharma
See all newsU.S. STOCKS ON THE MOVE-Quest Diagnostics, Tractor Supply, Dutch Bros
Arbutus rises after FDA lifts clinical hold for experimental hepatitis B drug
Brief: Arbutus Announces Final Results Of Its Us$230 Million Modified “Dutch Auction” Tender Offer
Brief: Arbutus Announces Preliminary Results Of Its Us$230 Million Modified “Dutch Auction” Tender Offer
U.S. STOCKS ON THE MOVE-Moderna, O-I Glass, Aveanna Healthcare